Letter to the Editor: A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

Autores/as

  • John Hagan

DOI:

https://doi.org/10.17161/kjm.vol1315733

Palabras clave:

timolol, ophthalmic solution, migraines, letter

Métricas

File downloads
288
Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

Descargas

Publicado

2021-03-02

Número

Vol. 13 (2020): KJM Supplement 2: Frontiers Edition

Sección

Letters to the Editor

Licencia

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

Cómo citar

Hagan, J. (2021). Letter to the Editor: A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kansas Journal of Medicine, 13(S2), 29-30. https://doi.org/10.17161/kjm.vol1315733